Inventiva (IVA) Divestments (2024 - 2025)
Inventiva's (IVA) quarterly Divestments came in at $90.4 million in Q2 2025, up 153.53% quarter-over-quarter from -$168.9 million in Q4 2024.
Inventiva (IVA) Divestments (2024 - 2025) Analysis & Trends
Inventiva's Divestments history runs 2 years deep, the most recent figure standing at $90.4 million for Q2 2025.
- On a quarterly basis, Divestments changed N/A year-over-year to $90.4 million in Q2 2025; TTM through Jun 2025 was $90.4 million, a N/A change from a year earlier, with the FY2024 full-year figure at -$168.9 million, changed N/A from the prior year.
- Divestments grew to $90.4 million in Q2 2025 per IVA's latest filing, from -$168.9 million in the prior quarter.
- Across five years, Divestments topped out at $90.4 million in Q2 2025 and bottomed at -$168.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 90.44 Mn |
| Dec 31, 2024 | -168.95 Mn |